Tampi R
Drugs Context. 2025; 14.
PMID: 40078953
PMC: 11900888.
DOI: 10.7573/dic.2024-12-2.
Merchant R, Dong Y, Kumari S, Murphy D
Front Med (Lausanne). 2025; 12:1540050.
PMID: 40078384
PMC: 11897001.
DOI: 10.3389/fmed.2025.1540050.
Grimaldi L, Cavallaro R, De Angelis D, Fuso A, Sancesario G
Molecules. 2025; 30(5).
PMID: 40076254
PMC: 11901974.
DOI: 10.3390/molecules30051027.
Ota H, Ohnuma T, Kodama A, Shimizu T, Sugawara K, Yamamoto F
Cells. 2025; 14(5).
PMID: 40072069
PMC: 11898884.
DOI: 10.3390/cells14050340.
Wang T, He H, Shi Y, Su N, Zhu M, Yan F
Gen Psychiatr. 2025; 38(2):e101736.
PMID: 40070969
PMC: 11891523.
DOI: 10.1136/gpsych-2024-101736.
Challenges and Opportunities in Implementing a Multicomponent Dementia Caregiver Program in a Complex Healthcare System.
Warren C, Ashcraft L, Peeples A, Piazza K, Goodman O, Gitlin L
Inquiry. 2025; 62:469580251322364.
PMID: 40070359
PMC: 11898023.
DOI: 10.1177/00469580251322364.
Economic Implications of Off-Road Cycle Lanes to Increase Physical Activity and Reduce Sex and Gender Differences in the Risk of Dementia.
Walbaum M, Aguzzoli E, Castro-Aldrete L, Cyhlarova E, Chadha A, Knapp M
Int J Geriatr Psychiatry. 2025; 40(3):e70067.
PMID: 40069575
PMC: 11896945.
DOI: 10.1002/gps.70067.
Factors associated with adherence to tablet-based cognitive training: J-MINT study.
Sugimoto T, Uchida K, Sato K, Yokoyama Y, Onoyama A, Fujita K
Alzheimers Dement (N Y). 2025; 11(1):e70062.
PMID: 40065916
PMC: 11891571.
DOI: 10.1002/trc2.70062.
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances.
Jiang Q, Liu J, Huang S, Wang X, Chen X, Liu G
Signal Transduct Target Ther. 2025; 10(1):76.
PMID: 40059211
PMC: 11891338.
DOI: 10.1038/s41392-025-02145-7.
Prediction of hearing aid cognitive outcomes in age-related hearing loss.
Voss P, Martinez-Moreno Z, Prevost F, Zeitouni A, Lopez Valdes A, de Villers-Sidani E
Front Aging Neurosci. 2025; 17:1548526.
PMID: 40051463
PMC: 11882528.
DOI: 10.3389/fnagi.2025.1548526.
Adherence and aerobic exercise intensity in live online exercise sessions for older adults with mild cognitive impairment: Insights from the Japan-Multimodal Intervention Trial for the Prevention of Dementia.
Sugimoto T, Uchida K, Yokoyama Y, Onoyama A, Fujita K, Kuroda Y
JAR Life. 2025; 14:100003.
PMID: 40046640
PMC: 11863878.
DOI: 10.1016/j.jarlif.2025.100003.
["Good vision in care facilities" : Qualitative evaluation study from the perspective of the vision officers].
Olschowka N, Altenbuchner A, Sturzbecher L, Wolf K, Himmelreich L, Gehr T
Z Gerontol Geriatr. 2025; .
PMID: 40045106
DOI: 10.1007/s00391-025-02422-8.
Prevalence of dementia risk factors in the Oxford Brain Health Clinic.
Blane J, Gillis G, Griffanti L, Mitchell R, Pretorius P, Forster S
Sci Rep. 2025; 15(1):7765.
PMID: 40044700
PMC: 11882794.
DOI: 10.1038/s41598-025-91178-7.
Detection of cognitive impairment, dementia and associated risk factors among Aboriginal and Torres Strait Islander peoples: Retrospective baseline audit results from a stepped-wedge cluster-randomised controlled trial.
Bradley K, Hughson J, Hyde Z, Atkinson D, Russell S, Quigley R
Australas J Ageing. 2025; 44(1):e70007.
PMID: 40044610
PMC: 11882482.
DOI: 10.1111/ajag.70007.
Changes in Loneliness, Social Isolation, and Social Support: A Gender-Disaggregated Analysis of Their Associations With Dementia and Cognitive Decline in Older Adults.
Htun H, Teshale A, Sun H, Ryan J, Owen A, Woods R
Int J Geriatr Psychiatry. 2025; 40(3):e70065.
PMID: 40044457
PMC: 11882408.
DOI: 10.1002/gps.70065.
Sex differences in age-associated neurological diseases-A roadmap for reliable and high-yield research.
Bonkhoff A, Coughlan G, Perosa V, Alhadid K, Schirmer M, Regenhardt R
Sci Adv. 2025; 11(10):eadt9243.
PMID: 40043111
PMC: 11881909.
DOI: 10.1126/sciadv.adt9243.
Physical Activity, Alzheimer Plasma Biomarkers, and Cognition.
Kim S, Shin D, Ham H, Kim Y, Gu Y, Kim H
JAMA Netw Open. 2025; 8(3):e250096.
PMID: 40042844
PMC: 11883494.
DOI: 10.1001/jamanetworkopen.2025.0096.
Demographic and clinical characteristics of initial patients receiving amyloid-targeting treatments in the United States after regulatory approval.
Mattke S, Yue S, Becker A, Liu Y
Alzheimers Dement. 2025; 21(3):e70054.
PMID: 40042495
PMC: 11881614.
DOI: 10.1002/alz.70054.
A comparative study of methods for dynamic survival analysis.
de Swart W, Loog M, Krijthe J
Front Neurol. 2025; 16:1504535.
PMID: 40040908
PMC: 11876041.
DOI: 10.3389/fneur.2025.1504535.
Adaptation and validation of the modified Egyptian Arabic version of Addenbrooke's Cognitive Examination III (VI-ACE-III) for assessing cognitive impairment in visually impaired elderly.
Abdelsalam S, Matter A, El-Hariri H, Assaf A, Khater M, Tawfik H
BMC Geriatr. 2025; 25(1):145.
PMID: 40038620
PMC: 11877952.
DOI: 10.1186/s12877-025-05784-1.